American Res Stock (NASDAQ:AREC), Trade Ideas

American Res

American Resources Corp is a next-generation, environmentally, and socially responsible supplier of high-quality raw materials to the new infrastructure market. The firm is focused on the extraction and processing of metallurgical carbon, an essential ingredient used in steelmaking, critical and rare earth minerals for the electrification market, and reprocessed metal to be recycled. The firm has a growing portfolio of operations located in the Central Appalachian basin of eastern Kentucky and southern West Virginia where premium quality metallurgical carbon and rare earth mineral deposits are concentrated. Its business model provides a significant opportunity to scale its portfolio of assets to meet the growing global infrastructure and electrification markets.

Analyst Color

Equities

News

Penny Stocks

Price Target

Reiteration

Markets

Analyst Ratings

General

AREC

AREC Well-Funded To Develop Carbon And Rare Earth Concentrates: Analyst

American Resources Corp (NASDAQ: AREC) revealed that it 

American Resources Rejects $260M Unsolicited Bid For American Carbon

Long Ideas

Insider Trades

Pre-Market Outlook

Trading Ideas

CNTX

CRCW

PFHO

The Dow Jones closed higher by more than 370 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Context Therapeutics And 3 Other Stocks Under $2 Insiders Are Aggressively Buying

American Resources Corporation - Class A Common Stock

American Resources Corp

American Resources Corp Warrants (27/08/2024)

Needham analyst Mike Matson maintains Conmed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNMD#NYSE">CNMD</a>) with a Buy and lowers the price target from $129 to $107.

CNMD

Needham Maintains Buy on Conmed, Lowers Price Target to $107

TD Cowen analyst Andrew Charles maintains Chipotle Mexican Grill (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>) with a Buy and raises the price target from $3400 to $3500.

TD Cowen Maintains Buy on Chipotle Mexican Grill, Raises Price Target to $3500

Chinese smartphone maker&nbsp;Xiaomi&nbsp;Corporation&nbsp;(OTC:<a class="ticker" href="https://www.benzinga.com/stock/XIACY#OTC">XIACY</a>) has reportedly secured 75,723 orders for its SU7 electric sedan as of April 24, aiming to deliver over 10,000 units in June.
The delivery&nbsp;target,&nbsp;revealed during an event at the Beijing auto show, sets a record for an electric vehicle (EV) startup, reported Reuters.
The locked-in orders, representing those with non-refundable deposits, have accumulated within a month of the SU7&#8217;s late March launch, the report added.
Xiaomi eyes over 100,000 SU7 deliveries in 2024, with a commitment to keep its automotive business exclusively focused on the Chinese market for the next three years.
Also Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/24/04/38049010/xiaomis-entry-to-an-already-crowded-ev-market-could-make-things-even-worse-for-tesla" rel="noreferrer noopener">Xiaomi&#8217;s Entry To An Already Crowded EV Market Could Make Things Even Worse For Tesla</a>
The report further noted the company expedited deliveries of the standard and Max versions of the SU7 to April 18, 12 days ahead of schedule. Plans for Pro model deliveries&nbsp;are set&nbsp;for late May.
The SU7&#8217;s debut, borrowing design elements from Porsche, ignites a price competition in China&#8217;s EV market, undercutting&nbsp;Tesla Inc&#8217;s&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) Model 3 pricing.
Why It Matters: Xiaomi, established in 2010, has built a reputation for high-quality, reasonably priced smartphones. With the SU7, the company aims to replicate this success in the EV industry.
The entire&nbsp;range of&nbsp;the&nbsp;vehicle&nbsp;is expected&nbsp;to&nbsp;be priced&nbsp;between&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/asia/24/01/36838267/latest-tesla-china-rival-xiaomis-first-ev-may-not-be-so-cheap-as-expected" rel="noreferrer noopener">RMB 250,000 ($35,230) and RMB 370,000</a>.
Price Action: XIACY shares closed higher by 2.02% at $10.60&nbsp;on Wednesday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo via Shutterstock

Media

TSLA

XIACY

Tesla's Latest China Rival Xiaomi Registers Record Bookings For Its EV: Report

Xpeng Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) Vice Chairman and Co-President Brian Gu expressed his skepticism about the immediate future of <a href="https://www.benzinga.com/news/24/04/38376273/maybe-elon-musk-hints-driverless-teslas-may-debut-in-this-us-state-but-bugs-will-take-few-months-to">self-driving taxis</a> as a lucrative business.
What Happened: Gu, speaking at the Beijing auto show, said that the commercial viability of robotaxis is at least five years away, <a href="https://www.cnbc.com/2024/04/25/xpengs-gu-says-robotaxis-wont-be-a-real-business-for-at-least-five-years.html">reported</a> CNBC on Thursday. This timeline is notably longer than what Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk has suggested. Tesla is actively developing AI software for a robotaxi network.
&#8220;Right now it&#8217;s not something that we are considering when we are launching and planning the sales,&#8221; said Gu. Xpeng, a China-based electric car startup, has made driver-assist software a key selling point.
&#8220;To have a real, full-fledged commercial operation. I think it's more than 5 years away.&#8221;
Despite this, Gu acknowledged the interest in showcasing technology and achieving milestones in China, where companies like Baidu Inc. and Pony.ai have been authorized to charge for fully driverless taxis in certain areas.
See Also: <a href="https://www.benzinga.com/markets/equities/24/04/38395098/tesla-unveils-timeline-for-electric-semi-truck-production-first-units-to-external-customers-by-2?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Tesla Unveils Timeline For Scaling Up Electric Semi-Truck Production, First Units From New Factory To &#8216;Ex</a>
Why It Matters: Musk has been a vocal advocate for the potential of robotaxis, despite challenges such as recent <a href="https://www.benzinga.com/news/24/04/38373389/tesla-ceo-elon-musk-takes-swipe-at-waymo-says-cybertruck-might-be-needed-for-robotaxis-in-san-franci">vandalism incidents</a> and regulatory hurdles. He has even suggested that the <a href="https://www.benzinga.com/news/24/04/38396288/teslas-robotaxi-to-be-called-cybercab-elon-musk-says-self-driving-fleet-will-be-like-combination-of">Tesla Cybertruck</a> might be necessary for robotaxis in San Francisco.
Analysts have also been weighing in on Tesla&#8217;s next-generation vehicle future, with some seeing the company as a <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38411281/8-tesla-analysts-size-up-next-gen-vehicles-fsd-ai-and-more-potential-to-be-a-transf">transformational technology company</a> that could deliver outsized returns.
Goldman Sachs analysts have recognized Tesla as a leader in the autonomy and Advanced Driver-Assistance Systems (ADAS) landscape, projecting <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38314733/teslas-autonomous-driving-efforts-win-praise-from-goldman-sachs-wall-street-firm-pr">significant long-term growth</a> from its robotaxi services.
Read Next: <a href="https://www.benzinga.com/news/24/04/38285714/no-more-inventory-discounts-on-tesla-cars-as-ceo-elon-musk-says-sales-system-has-turned-complex-and?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">No More Inventory Discounts On Tesla Cars As CEO Elon Musk Says Sales System Has Turned &#8216;Complex And Inefficient&#8217;</a>
Image Via Shutterstock 
<div style="font-family: 'Lato', sans-serif">
<hr style="border: 0;height: 5px;background: #225aa9" />
<div style="background-color: #f5f5f5;background-position: center;background-size: cover;justify-content: center"></div>

 Engineered by 
 Benzinga Neuro, Edited by 
 
 <a href="None" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none"> 
 Kaustubh Bagalkote</a> 
 
 
<hr style="border: 0;height: 1px;background: #225aa9" />

 The GPT-4-based Benzinga Neuro content generation system exploits the 
 extensive Benzinga Ecosystem, including native data, APIs, and more to 
 create comprehensive and timely stories for you. 
 <a href="https://www.benzinga.com/topic/kaustubh-bagalkote" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Learn more.</a>
 
<hr style="border: 0;height: 5px;background: #225aa9" />
 </div>

Tech

XPEV

Tesla Is betting Big On Robotaxi, But This Rival Thinks Elon Musk's Vision Could Be 'More Than 5 Years Away'

Needham analyst Mike Cikos reiterates MongoDB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) with a Buy and maintains $465 price target.

Needham Reiterates Buy on MongoDB, Maintains $465 Price Target

<ul>
<li>Leverage ratio of 4.5%, in line with previous quarter</li>
<li>Provision for credit losses of &euro; 439 million, down 10% from &euro; 488 million in fourth quarter of 2023; full-year guidance reaffirmed at higher end of range of 25-30 basis points of average loans</li>
</ul>

Earnings

Deutsche Bank Reports Q1 Common Equity Tier 1 Capital Ratio Of 13.4% After Deductions For Shareholder Distributions And Business-driven Growth In Risk Weighted Assets

Deutsche Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DB#NYSE">DB</a>) reported quarterly earnings of €0.69 per share which beat the analyst consensus estimate of €0.62 by 11.29 percent. This is a 13.11 percent increase over earnings of €0.61 per share from the same period last year. The company reported quarterly sales of €7.779 billion which beat the analyst consensus estimate of €7.711 billion by 0.89 percent. This is a 1.29 percent increase over sales of €7.680 billion the same period last year.

Earnings Beats

Deutsche Bank Q1 2024 GAAP EPS €0.69 Beats €0.62 Estimate, Sales €7.779B Beat €7.711B Estimate

Bernstein analyst Daniel Roeska initiates coverage on General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) with a Outperform rating and announces Price Target of $55.

Initiation

Bernstein Initiates Coverage On General Motors with Outperform Rating, Announces Price Target of $55

Wedbush analyst Richard Anderson downgrades First Industrial Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FR#NYSE">FR</a>) from Outperform to Neutral and lowers the price target from $59 to $49.

Downgrades

Wedbush Downgrades First Industrial Realty to Neutral, Lowers Price Target to $49

Truist Securities analyst Miller Jump downgrades HashiCorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCP#NASDAQ">HCP</a>) from Buy to Hold and raises the price target from $27 to $35.

Truist Securities Downgrades HashiCorp to Hold, Raises Price Target to $35

Elon Musk&nbsp;reacted to a user&#8217;s jest about the whereabouts of a former&nbsp;OpenAI chief scientist&nbsp;Ilya Sutskever, after Greg Brockman shared a photo with Sam Altman and&nbsp;Nvidia&nbsp;CEO&nbsp;Jensen Huang. 
What Happened: On Wednesday, Brockman, the president of ChatGPT&#8217;s parent company, took to X, formerly Twitter, and <a href="https://www.benzinga.com/news/24/04/38422652/jensen-huang-hand-delivers-nvidias-first-dgx-h200-gpu-to-openais-sam-altman-to-advance-ai-computing">shared the photo</a> saying, &#8220;First NVIDIA DGX H200 in the world, hand-delivered to OpenAI and dedicated by Jensen &#8216;to advance AI, computing, and humanity.'&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">First <a href="https://twitter.com/nvidia?ref_src=twsrc%5Etfw">@NVIDIA</a> DGX H200 in the world, hand-delivered to OpenAI and dedicated by Jensen &quot;to advance AI, computing, and humanity&quot;: <a href="https://t.co/rEJu7OTNGT">pic.twitter.com/rEJu7OTNGT</a>
&mdash; Greg Brockman (@gdb) <a href="https://twitter.com/gdb/status/1783234941842518414?ref_src=twsrc%5Etfw">April 24, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Following this, an X user, humorously commented,&nbsp;&#8220;Tell the truth. Is Ilya&nbsp;in the box?,&#8221; to which Tesla and SpaceX CEO&nbsp;Elon Musk responded&nbsp;with a face with tears&nbsp;of joy emoji.
See Also:&nbsp;<a href="https://www.benzinga.com/news/24/04/38400945/metas-massive-1b-bet-on-nvidia-h100-gpu-cluster-will-dwarf-every-other-companys-target-but-zuckerber?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Meta&#8217;s Massive $1B Bet On Nvidia H100 GPU Cluster Will Dwarf Every Other Company&#8217;s Target, But Zuckerberg Reveals Original Goal Was This, Not AI</a>
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">&#x1f602;
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1783262978193948851?ref_src=twsrc%5Etfw">April 24, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The <a href="https://www.benzinga.com/news/24/03/37809836/nvidia-reveals-blackwell-gpu-highlights-partnerships-with-top-companies-at-gtc-the-whole-industry-is">DGX H2000 is being hailed</a> as the most potent GPU globally. The H200 GPU succeeds the highly acclaimed H100 GPU, boasting 1.8 times the memory capacity and 1.4 times the bandwidth of its predecessor.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: The mention of&nbsp;Sutskever, OpenAI&#8217;s chief scientist, in the user&#8217;s comment has sparked renewed interest in <a href="https://www.benzinga.com/news/24/03/37814793/sam-altman-laughs-off-speculation-about-openais-ilya-sutskevers-whereabouts-i-really-hope-we-work-to">Sutskever&#8217;s mysterious absence</a>. Sutskever has been missing from the public eye since his <a href="https://www.benzinga.com/23/11/35861681/sam-altman-and-greg-brockman-shocked-and-saddened-after-removal-from-openai-over-google-meet">controversial &#8220;palace coup&#8221; in November</a>. 
His absence has been a subject of speculation, with even Sam Altman, OpenAI&#8217;s CEO, addressing the issue in a podcast. &#8220;I love Ilya. I have tremendous respect for Ilya. I really hope we work together for certainly the rest of my career,&#8221; the OpenAI CEO said in a conversation with Lex Fridman. 
Last year, following OpenAI employees&#8217; <a href="http://benzinga.com/news/23/11/35871393/openais-internal-strife-cto-coo-and-other-employees-unite-in-support-of-sam-altman" target="_blank" rel="noreferrer noopener">open rebellion</a> against the sudden firing of Altman and Brockman, Sutskever said that he would try to reunite the company. &#8220;I deeply regret my participation in the board's actions. I never intended to harm OpenAI,&#8221; he said at the time. 
Helen Toner, another board member who was part of Sutskever&#8217;s bid to remove Altman <a href="https://www.benzinga.com/news/23/11/35912540/sam-altman-tried-to-push-out-another-board-member-before-losing-and-getting-ousted-himself-report">left ChatGPT-parent</a> but Sutskever is still a part of it.
Check out more of Benzinga's Future Of Consumer Tech by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:&nbsp;<a href="https://www.benzinga.com/news/24/04/38357333/elon-musk-reacts-to-tucker-carlson-saying-theres-ton-of-evidence-that-aliens-live-among-us-with-6000?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Tesla CEO Elon Musk Says He Feels &#8216;Like A Wince&#8217; When Saying &#8216;GPU&#8217; As He Boasts Rapid Progress With AI Compute: &#8216;Need A New Word&#8217;</a>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photos courtesy: Shutterstock

Elon Musk Laughs As X User Quip On Nvidia CEO Jensen Huang's Picture With Sam Altman And Greg Brockman: 'Is Ilya In The Box?'

Retail pharmacy giant&nbsp;Walgreens Boots Alliance Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) is bolstering its specialty pharmacy services, aiming&nbsp;to enhance patient outcomes and value for stakeholders.
The company unveiled Walgreens Specialty Pharmacy, an encompassing initiative to cater to patients with complex, chronic conditions while fostering profitable partnerships.
Read Next:&nbsp;<a target="_blank" href="https://www.benzinga.com/news/large-cap/24/03/37967312/walgreens-challenges-nearly-1b-arbitration-award-over-alleged-breach-of-covid-19-test-business-con" rel="noreferrer noopener">Walgreens Challenges Nearly $1B Arbitration Award Over Alleged Breach of COVID-19 Test Business&nbsp;Contract</a>
Walgreens Specialty Pharmacy introduces a comprehensive suite of services, including gene and cell therapy solutions, marking a significant advancement in the company&#8217;s healthcare offerings.
Anchored by an 18,000-square-foot Innovation Center in Pittsburgh, Pennsylvania, the initiative focuses on managing therapy complexities and ensuring patient success.
Under the expanded business, Walgreens will operate four central specialty pharmacies, each with national accreditations and expertise in dispensing intricate medications.
Additionally, the company&#8217;s expansive network comprises nearly 300 community-based specialty&nbsp;pharmacies,&nbsp;strategically positioned for swift medication access and tailored patient services.
Also Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/news/earnings/24/03/37981845/walgreens-boots-alliance-cuts-higher-end-of-2024-profit-outlook-takes-5-8b-impairment-charge-relate" rel="noreferrer noopener">Walgreens Boots Alliance Cuts Higher End Of 2024 Profit Outlook, Takes $5.8B Impairment Charge Related To VillageMD&nbsp;Business</a>
With over 1,500 specialty-trained pharmacists and 5,000 patient advocacy support members, Walgreens Specialty Pharmacy&nbsp;is primed&nbsp;to address the burgeoning demand for specialized care.
Specialty medications constitute a significant portion of the U.S. prescription drug market, driving the need for tailored solutions.
Walgreens Specialty Pharmacy aims to meet this demand by streamlining care coordination across stakeholders, thereby enhancing patient access and driving cost efficiencies.
Effective August 1, 2024, AllianceRx Walgreens Pharmacy will transition to Walgreens Specialty Pharmacy, offering enhanced resources and clinical support to patients.
Walgreens&nbsp;stock lost over 48% in the last 12 months. Investors can gain exposure to the stock via&nbsp;Invesco High Yield Equity Dividend Achievers ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEY#NASDAQ">PEY</a>) and&nbsp;Invesco Dow Jones Industrial Average Dividend ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DJD#NYSE">DJD</a>).
Price Action: WBA shares are trading higher by 0.79% at $17.94 in premarket at last check Thursday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo via Wikimedia Commons

Walgreens Expands Specialty Pharmacy Business To Include Gene and Cell Services: Details

HSBC analyst Parash Jain upgrades United Parcel Service (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) from Hold to Buy and raises the price target from $150 to $170.

Upgrades

HSBC Upgrades United Parcel Service to Buy, Raises Price Target to $170

Keybanc analyst Kenneth Zener upgrades Sherwin-Williams (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHW#NYSE">SHW</a>) from Sector Weight to Overweight and announces $400 price target.

Keybanc Upgrades Sherwin-Williams to Overweight, Announces $400 Price Target

PureTech Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTC#NASDAQ">PRTC</a>) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.93) by 74.19 percent. The company reported $3.330 million in sales this quarter. This is a 78.68 percent decrease over sales of $15.618 million the same period last year.

PRTC

PureTech Health FY 2023 GAAP EPS $(0.24) Beats $(0.93) Estimate, Sales $3.330M Down From $15.618M YoY

The CHIPS and Science Act grants of $6.1 billion will support Micron&#39;s plans to invest approximately $50 billion in gross capex for U.S. domestic leading-edge memory manufacturing through 2030. These grants and additional state and local incentives will support the construction of one leading-edge memory manufacturing fab to be co-located with the company&#39;s existing leading-edge R&amp;D facility in Boise, Idaho and the construction of two leading-edge memory fabs in Clay, New York.

Government

Large Cap

Micron Technology And The Biden-Harris Administration Have Signed A Non-binding Preliminary Memorandum Of Terms For $6.1B In Funding Under The CHIPS And Science Act To Support Planned Memory Manufacturing In Idaho And New York

Full-year 2024 revenues are expected to increase&nbsp;1.5%&nbsp;to&nbsp;3.5%&nbsp;on a reported basis and increase&nbsp;1%&nbsp;to&nbsp;3%&nbsp;organically, after excluding the expected impacts of acquisitions, divestitures and foreign currency movements.

Guidance

ALLE

Allegion Reaffirmed FY24 Outlook: Adjusted EPS At $7.00-$7.15 Vs. $7.07 Estimate, Revenue Growth At 1.5%-3.5%

Needham analyst Quinn Bolton upgrades Silicon Laboratories (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLAB#NASDAQ">SLAB</a>) from Hold to Buy and announces $150 price target.

SLAB

Needham Upgrades Silicon Laboratories to Buy, Announces $150 Price Target

. This will enable TCO to expand Tengiz crude oil production by an incremental 12 million tons per annum (260,000 barrels a day)

Commodities

Chevron announced that its 50% owned affiliate Tengizchevroil has commenced operations at its Wellhead Pressure Management Project at the Tengiz oil field in Kazakhstan, The final phase of TCO's expansion project, is on track to conclude in 1H 2025

Needham analyst Ami Fadia reiterates Biogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NASDAQ">BIIB</a>) with a Buy and maintains $294 price target.

BIIB

Needham Reiterates Buy on Biogen, Maintains $294 Price Target

American Resources Corp (AREC) leads the Coking Coal industry with an overall score of 64. AREC is up 19.85% so far this year after the company closed yesterday at $1.57.  The overall score measures the company's performance based-off both short and long term indicators and means that AREC scores better than 64% of the ove

Should American Resources Corp (AREC) Stock Be in Your Portfolio?

Earnings week ahead: Walgreens Boots Alliance, Carnival, GameStop and more

American Resources Corp (AREC) leads the Coking Coal industry with an overall score of 58. AREC is up 1.50% so far this year after the company closed yesterday at $1.35.  The overall score measures the company's performance based-off both short and long term indicators and means that AREC scores better than 58% of the over

Is American Resources Corp (AREC) Stock Near the Top of the Coking Coal Industry?

American Resources Q4 Earnings Preview

Notable earnings after Thursday's close

American Resources GAAP EPS of -$0.15 misses by $0.11, revenue of $16.7M

American Resources Corporation (AREC) Q4 2023 Earnings Call Transcript

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
American Res (NASDAQ:<a href="https://investorplace.com/stock-quotes/arec-stock-quote/">AREC</a>) just reported results for the fourth quarter of 2023.<ul><li>American Res reported earnings per share of -15 cents. This was below the analyst estimate for EPS of -4 cents.</li><li>The company reported revenue of $66,404.</li><li>This was 96.98% worse than the analyst estimate for revenue of $2.20 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/03/arec-stock-earnings-american-res-for-q4-of-2023/">AREC Stock Earnings: American Res Misses EPS, Misses Revenue for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

AREC Stock Earnings: American Res Misses EPS, Misses Revenue for Q4 2023

These Basic Materials stocks are trading higher:-Hycroft Mining Holding Corporation (HYMC) stock is trading at $2.67, a gain of $0.46, or 20.01%, on high volume.  Hycroft Mining Holding Corporation gets a Sentiment Score of Bearish from InvestorsObserver.  -Universal Stainless and Alloy Products Inc (USAP) stock is trading

Basic Materials Stocks Making Moves Monday: HYMC, USAP, AUST, CDE, AYASF, HLP, MTRN, AREC

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
<a href="https://investorplace.com/stock-types/penny-stocks/">Penny stocks</a> could be your ticket to striking it rich. But don&rsquo;t expect easy money! While these thinly traded sub-$5 stocks offer the tantalizing prospect of turning pocket change into a small fortune, finding the diamonds in the rough is easier said than done. This has led to this list of penny stocks to buy.



For every penny stock that skyrockets, there are dozens that fizzle out and leave investors holding the bag. It takes a keen eye and a high-risk tolerance to separate the winners from the losers in this ultra-volatile space. But for those daring enough to try, the potential rewards can be life-changing.



You should steer clear of the cash-burning biotechs and unproven startups that litter this space. Instead, focus on quality businesses with solid fundamentals and a clear path to profitability. These hidden gems may not grab headlines yet, but their underlying growth could soon propel them into the stratosphere once Wall Street catches on.



Now, can you realistically expect a 5X gain by year&rsquo;s end? Probably not &ndash; that would be an exceptional outcome even for a penny stock. But with the right picks, doubling or tripling your money is certainly within the realm of possibility as these undervalued businesses start driving gains. And who knows, you may just uncover the next big multi-bagger that turns your modest stake into a small fortune over the next few years. Let&rsquo;s dive into penny stocks to buy.



<h2>CAB Payments (CABPF)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/10/smartphone-mobile-financial-fintech-1600-300x169.jpg" alt="Illustration of phone with dollar sign and other graphics symbolizing fintech displayed on and around it, with a blue background. Fintech Stock Bargains"><div>Source: shutterstock.com/ZinetroN</div></div>CAB Payments (OTCMKTS:<a href="https://investorplace.com/stock-quotes/cabpf-stock-quote/">CABPF</a>) is a U.K.-based company specializing in business-to-business cross-border payments and foreign exchange, particularly in hard-to-reach markets. It operates through Crown Agents Bank, offering products like EMpower FX, EMpower Payments, EMpower Connect, and EMpower Pensions. I believe it&rsquo;s a smart move to buy into this stock as cross-border payments have been rising significantly. International immigration is one major driving force here, coupled with fintech&rsquo;s meteoric rise in popularity. People from remote or obscure countries often struggle to send money back through traditional channels to emerging nations. CABPF specializes in bridging that gap, and as immigration and remittance outflows swell, it seems poised for growth.



While the stock is still down 53% from its highs, it has gained over 150% since October and continues climbing aggressively. <a href="https://www.google.com/finance/quote/CABPF:OTCMKTS">Q4 revenue surged 71%</a>, and analysts expect CABPF to rake in <a href="https://seekingalpha.com/symbol/CABPF/earnings/estimates">$183 million in revenue for all of 2024</a> &ndash; with that figure projected to climb to nearly $250 million by 2026. Their scalable, transparent, and cost-effective products boast an impressive 96% customer retention rate and 150% net revenue retention. Yet despite this torrid growth trajectory, you&rsquo;re paying just 12 times earnings for the stock. That&rsquo;s an absolute steal among penny stocks to buy.



<h2>Stereotaxis (STXS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600-300x169.png" alt="Biotechnology stocks, biomedical stocks"><div>Source: aslysun / Shutterstock.com</div></div>As I&rsquo;ve said many times before, I typically avoid biotech and pharma companies like the plague. However, this healthcare company doesn&rsquo;t really fall into that category, despite appearances. What Stereotaxis (NYSEMKT:<a href="https://investorplace.com/stock-quotes/stxs-stock-quote/">STXS</a>) does is get involved with robotics &ndash; an area I find far more intriguing. Stereotaxis designs, manufactures, and markets robotic systems and instruments for treating abnormal heart rhythms. Its product lineup includes the Niobe ES Robotic Magnetic Navigation System, the Odyssey solution for information management, and the Vdrive Robotic Navigation System for remotely controlling navigation devices.



More specifically though, I&rsquo;m interested in the penny stocks&rsquo; <a href="https://ir.stereotaxis.com/news-releases/news-release-details/stereotaxis-announces-regulatory-submissions-magic-ablation">MAGiC Catheter potentially gaining approval</a>. The MAGiC catheter is a robotically navigated magnetic interventional ablation catheter designed for minimally invasive cardiac ablation procedures. Its human trial was a resounding success, with all 20 patients achieving acute success and zero adverse events reported. This makes it one of those penny stocks to buy.



Stereotaxis has submitted the MAGiC catheter to regulators in the E.U. and U.S., with expectations of CE Mark approval in May or June. It also plans to submit the semi-mobile robot to regulators in Q2, anticipating European approval by mid-2024 and the U.S. green light in Q3. I believe the stock could continue its bullish tear, having already rallied nearly 63% year-to-date. There&rsquo;s no cash crunch here either, with ample reserves to guide Stereotaxis to profitability. If that MAGiC Catheter gets the regulatory stamp of approval, it could catalyze the next leg higher.



<h2>Creative Realities (CREX)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/02/data-automation-cloud-marketing-300x169.png" alt="An image of a robot reaching toward a laptop, surrounded by chat bubbles and graphs"><div>Source: klyaksun/Shutterstock</div></div>Creative Realities (NASDAQ:<a href="https://investorplace.com/stock-quotes/crex-stock-quote/">CREX</a>) is a digital marketing tech company offering digital signage and media solutions to enhance communications across a wide range of out-of-home environments. The company&rsquo;s solutions encompass digital merchandising systems and omni-channel customer engagement systems. It&rsquo;s growing at a blistering pace, and I believe landing major corporate contracts could propel it to the upper echelons of its niche.



In Q4, <a href="https://www.google.com/finance/quote/CREX:NASDAQ?sa=X&amp;ved=2ahUKEwjJjdyrv7WFAxVuqVYBHZQ1CeQQ3ecFegQIIhAX">revenue soared 38% to $14.5 million</a>, and the company is profitable with $1.4 million in net income. Yet it sports a mere $35 million market cap &ndash; peanuts compared to its growth runway. Software and marketing firms routinely fetch 10-20x sales valuations these days, so CREX trading at just 0.5x forward sales looks like an absolute bargain to me. We&rsquo;re also eyeing the potential for <a href="https://seekingalpha.com/symbol/CREX/earnings/estimates">EPS to triple from 10 cents in 2024 to 32 cents</a> next year. Do the math, and you&rsquo;re paying a measly 10x the 2025 EPS estimate.



Creative Realities guided to hit between $60-80 million in revenue for 2024. That could generate anywhere from 27% to 70% annual growth. Even at the lower end of guidance, we&rsquo;re still talking about torrid top-line expansion for a company valued at a mere 0.5x sales. To me, that spells a bargain with multi-bagger potential once Wall Street wakes up to penny stocks like this one.



<h2>FLYHT Aerospace Solutions (FLYLF)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/12/aerospace-300x169.jpg" alt="a private plane inside a hangar is prepared for a flight. represent aerospace stocks"><div>Source: Shutterstock</div></div>The aerospace industry has been soaring over the past few years, with private flying in particular experiencing a boom &ndash; excluding that brief COVID-induced turbulence, of course. As travel normalizes, we&rsquo;re looking at new heights for penny stocks in this sector, fueled in part by Trump&rsquo;s tax cuts allowing jet-setters to write off their winged chariots as business expenses. FLYHT Aerospace Solutions (OTCMKTS:<a href="https://investorplace.com/stock-quotes/flylf-stock-quote/">FLYLF</a>) provides real-time aircraft intelligence and cockpit communications for this high-flying industry. While the company&rsquo;s current operations are in the red, the valuation appears attractively priced for takeoff.



Despite deriving 50% of revenue from high-margin, incredibly sticky, and consistently expanding SaaS offerings, FLYLF&rsquo;s price-to-sales ratio hovers around just 1x. As I&rsquo;ve mentioned before, SaaS firms typically command far richer multiples, making this look like an absolute steal. Sure, profitability remains elusive for now. But we&rsquo;re eyeing near-breakeven EPS levels in 2024, and if that growth trajectory sustains, significant profits could soon follow &ndash; potentially fueling multibagger returns. Revenue is also <a href="https://seekingalpha.com/symbol/FLYLF/earnings/estimates">projected for 26% growth</a> this year, giving FLYLF a lengthy runway to spread its wings. This makes it one of those penny stocks to buy.



<h2>Pioneer Power Solutions (PPSI)</h2>



<a href="https://investorplace.com/wp-content/uploads/2022/11/shutterstock_1570147828-scaled-e1667921955402.jpg"><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/11/shutterstock_1570147828-scaled-e1667921955402-300x169.jpg" alt="a photo of a city with a digital grid overhead, showing the wide range of connectivity that comes with 5G. communications stocks"></a>Pioneer Power Solutions (NASDAQ:<a href="https://investorplace.com/stock-quotes/ppsi-stock-quote/">PPSI</a>) designs and manufactures electrical equipment through its Transmission and Distribution Solutions (T&amp;D) and Critical Power segments. Fair warning: this stock isn&rsquo;t for the faint of heart, exhibiting long-term volatility and swings that would make a pirate envious. But such choppiness is par for the course, and PPSI is now returning to bargain-basement levels &ndash; nearly back to where it traded a year ago. I believe this could represent an attractive entry point with limited downside and significant upside potential.



In Q3, <a href="https://www.google.com/finance/quote/PPSI:NASDAQ">revenue nearly doubled year-over-year to $12.4 million</a>, and analysts expect the infrastructure revolution to drive robust demand for PPSI&rsquo;s electrical offerings. EV and AI adoption loom as additional catalysts playing out over the next few years. Earnings are forecast to soar from <a href="https://seekingalpha.com/symbol/PPSI/earnings/estimates">21 cents per share in 2024 to nearly $3 by 2033</a>, with revenue climbing from $53 million to $220 million over that span. Yet, you&rsquo;re paying just 7 times 2025&rsquo;s estimated earnings &ndash; an absolute steal for penny stocks like PPSI positioned at the intersection of multiple powerful trends.



<h2>Braemar Hotels (BHR)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/07/hotels-1600-300x169.jpg" alt="Woman standing in hotel room with luggage looking at the view. Hotel stocks."><div>Source: Boyloso / Shutterstock</div></div>Braemar Hotels &amp; Resorts (NYSE:<a href="https://investorplace.com/stock-quotes/bhr-stock-quote/">BHR</a>) is a real estate investment trust focused on investing in luxury hotels and resorts through acquisitions or new development. I&rsquo;ve ranked this one lower given its higher risk profile, but for those chasing outsized gains, it could be worth a look. The company likely won&rsquo;t see much stock appreciation driven by growth, as it&rsquo;s expanding in the low single digits. Instead, my focus is on earnings growth potential. BHR trades at just 4 times forward earnings &ndash; a bargain valuation reflecting its hefty $1.2 billion debt load, massive compared to its $140 million market cap at the time of writing.



However, I believe the stock could still deliver multibagger returns. With interest rate cuts on the horizon, that should relieve pressure from interest expenses. Moreover, BHR is generating hefty profits despite those payments, sporting a lofty 9.4% dividend yield. If management can continue deleveraging while capitalizing on the recovery in travel and tourism, this high-risk, high-reward play could have further room to run. It&rsquo;s also one of those penny stocks to buy.



<h2>American Resources (AREC)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/mining1600-300x169.jpg" alt="construction workers point at mining equipment in the near distance"><div>Source: Shutterstock</div></div>American Resources Corporation (NASDAQ:<a href="https://investorplace.com/stock-quotes/arec-stock-quote/">AREC</a>) supplies raw materials to the infrastructure and electrification markets, producing inputs for steel, alloys, magnets, lithium-ion batteries, and metals. Its offerings are already witnessing elevated demand from onshoring trends in up-and-coming U.S. industries. However, I see even greater potential demand for domestically produced rare earth elements going forward as the nation aims to reduce its dependence on China.



AREC has acquired mining rights to several large areas, with potential deals that could significantly increase shareholder value. The company also boasts a promising processing business that could disrupt China&rsquo;s dominance in rare earth metals and strategically important minerals markets. With <a href="http://seekingalpha.com/symbol/AREC/earnings/estimates">revenue expected to surge 88%</a> in 2024, AREC could easily transform into a multibagger investment once its operations start firing on all cylinders.



The raw materials sector is notoriously cyclical, but AREC seems well-positioned to ride multiple secular tailwinds &ndash; from electrification and domestic manufacturing to national security priorities around critical mineral supply chains. If management can deftly execute on its ambitious growth plans, this under-the-radar play could emerge as a surprising winner in the years ahead.



On the date of publication, Omor Ibne Ehsan did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines.</a>
<div>Omor Ibne Ehsan is a writer at InvestorPlace. He is a self-taught investor with a focus on growth and cyclical stocks that have strong fundamentals, value, and long-term potential. He also has an interest in high-risk, high-reward investments such as cryptocurrencies and penny stocks. You can follow him on <a href="https://www.linkedin.com/in/omor-ibne-ehsan-56068022b/">LinkedIn</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/04/7-penny-stocks-that-could-5x-by-the-end-of-2024/">7 Penny Stocks That Could 5X by the End of 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

7 Penny Stocks That Could 5X by the End of 2024

ACHV

AGRX

AMPE

APTO

AQMS

ASTS

ATNM

AULT

AUST

AXDX

AYASF

AYRO

BLRX

BZFD

CABPF

CMCL

CREX

CTAS

CWCO

DARE

DCTH

DLNG

DNMR

DOMH

DOYU

DTIL

ERNA

ESLT

FLYLF

GDNSF

GLPG

GREE

HEPS

HYMC

IDEX

INMB

ITRM

LGMK

LITB

MAXN

MDAI

MTRN

NCNO

NDRA

NRXP

NVVE

OGEN

ORGS

OUST

PAYS

PAYX

PLBY

PPSI

REED

REKR

RKDA

SMTC

STIX

STXS

TIVC

USAP

VIOT

VRNT

VSTM

VUZI

WATT

WPRT

WRAP

XELA

XXII

ZVRA

Management

Press Releases

American Resources Corporation Issues Corrected Press Release for the Appoint of His Excellency Baba Kamara to the Board of Directors of ReElement Technologies Africa Ltd. Subsidiary

American Resources Corporation to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024

American Resources Corporation's ReElement Technologies Announces Successful Execution and Closing of Bond Purchase Agreement for $150 Million of Kentucky Industrial Building Revenue Bonds for its Kentucky Lithium Refinery

American Resources Corporation Reports Full Year 2023 Financial Results and Provides Business Outlook

American Resources Corporation's American Carbon Corporation Provides Updated Rare Earth Analysis From West Virginia Project

American Resources Corporation's American Carbon Corporation Receives Additional $1,055,780 in Environmental Bond Releases

American Resources Corporation Sets Record Date of May 14, 2024 for Special Dividend of American Carbon Corporation Division

Events

American Resources Corporation's ReElement Technologies Announces April Slate of Conferences and Events

American Resources Corporation's ReElement Technologies Expands Its Exclusive Rights for Rare Earth Element Purification Technology to Include All Feedstocks

American Resources Corporation's ReElement Technologies Launches Powered By ReElement Service Offering

RMCO

Arch Resources, Inc. Class A Common Stock

Arch Resources

Alliance Resource Partners, L.P. - Common Units Representing Limited Partnership Interests